EUVIMEDEUVIMED entdecken
Crossref

EPHB2 Knockdown Mitigated Myocardial Infarction by Inhibiting MAPK Signaling

Xiaoyan Jiang, Wenhua Wang, Haofei Kang iD

Advanced Biology · 2024

DOI: 10.1002/adbi.202300517 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Biology, 2024. Verfasst von Xiaoyan Jiang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Cardiovascular Medicine, Yantai Fushan People's Hospital, Yantai, Shandong, 265500, P. R. China. Hauptthemen laut MEDLINE: Myocardial Infarction, Receptor, EphB2, MAP Kinase Signaling System. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 62 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Myocardial infarction (MI) is a common type of cardiovascular disease. The incidence of ventricular remodeling dysplasia and heart failure increases significantly after MI. The objective of this study is to investigate whether erythropoietin hepatocellular receptor B2 (EPHB2) can regulate myocardial injury after MI and explore its regulatory pathways. EPHB2 is significantly overexpressed in the heart tissues of MI mice. The downregulation of EPHB2 alleviates the cardiac function damage after MI. Knockdown EPHB2 alleviates MI‐induced myocardial tissue inflammation and apoptosis, and myocardial fibrosis in mice. EPHB2 knockdown significantly inhibits the activation of mitogen activated kinase‐like protein (MAPK) pathway in MI mice. Moreover, EPHB2 overexpression significantly promotes the phosphorylation of MAPK pathway‐related protein, which can be reversed by MAPK‐IN‐1 (an MAPK inhibitor) treatment. In conclusion, silencing EPHB2 can mitigate MI‐induced myocardial injury by inhibiting MAPK signaling in mice, suggesting that targeting EPHB2 can be a promising therapeutic target for MI‐induced myocardial injury.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myocardial InfarctionReceptor, EphB2MAP Kinase Signaling SystemAnimalsMiceMaleGene Knockdown TechniquesApoptosisMice, Inbred C57BLMyocardiumDisease Models, Animal

Stichwörter der Autor:innen

EPHB2MAPK pathwayheart failuremyocardial infarction

Substanzen

Receptor, EphB2Ephb2 protein, mouse

Autor:innen und Institutionen

  • Cardiovascular Medicine, Yantai Fushan People's Hospital, Yantai, Shandong, 265500, P. R. China.
  • The First Ward of Cardiovascular Medicine, YanTai YanTaiShan Hospital, Yantai, Shandong, 264000, P. R. China.

ORCID-Profile: Haofei Kang

Zitieren

APA

Jiang, X., Wang, W., & Kang, H. (2024). EPHB2 Knockdown Mitigated Myocardial Infarction by Inhibiting MAPK Signaling. Advanced Biology. https://doi.org/10.1002/adbi.202300517

Vancouver

Jiang X, Wang W, Kang H. EPHB2 Knockdown Mitigated Myocardial Infarction by Inhibiting MAPK Signaling. Advanced Biology. 2024. doi:10.1002/adbi.202300517

BibTeX
@article{Jiang2024,
  author = {Jiang, Xiaoyan and Wang, Wenhua and Kang, Haofei},
  title = {EPHB2 Knockdown Mitigated Myocardial Infarction by Inhibiting MAPK Signaling},
  journal = {Advanced Biology},
  year = {2024},
  doi = {10.1002/adbi.202300517}
}
Kostenlos starten →